Events/Photo Gallery

  • Home ›   Events/Photo Gallery ›   Consulate General of India, San Francisco in collaboration with Stanford Mussallem Center for Biodesign, organized a roundtable discussion on the “2026 U.S.–India Health Technology Partnership Summit

Consulate General of India, San Francisco in collaboration with Stanford Mussallem Center for Biodesign, organized a roundtable discussion on the “2026 U.S.–India Health Technology Partnership Summit

January 13, 2026

Consulate General of India, San Francisco in collaboration with Stanford Mussallem Center for Biodesign, organized a roundtable discussion on the “2026 U.S.–India Health Technology Partnership Summit
Consulate General of India, San Francisco in collaboration with Stanford Mussallem Center for Biodesign, organized a roundtable discussion on the “2026 U.S.–India Health Technology Partnership Summit
Consulate General of India, San Francisco in collaboration with Stanford Mussallem Center for Biodesign, organized a roundtable discussion on the “2026 U.S.–India Health Technology Partnership Summit
Consulate General of India, San Francisco in collaboration with Stanford Mussallem Center for Biodesign, organized a roundtable discussion on the “2026 U.S.–India Health Technology Partnership Summit
Consul General Dr. K. Srikar Reddy welcomed a distinguished group of entrepreneurs, researchers, investors, and physicians from med tech sector, along with Silicon Valley leaders from the venture capital and health technology ecosystems. Notable participants included Dr. Anurag Mairal, Director of Global Outreach Programs at Stanford Mussallem Center for Biodesign; Dr. Rajiv Doshi, MD, Adjunct Professor of Medicine and Director of the India Program at Stanford Mussallem Center for Biodesign; and prominent entrepreneurs of Indian origin working in Silicon Valley, including Padma Bhushan awardee Mr. Vinod Dham and Dr. Nandini Tandon, along with other senior executives from leading health innovation ecosystems.

The roundtable featured in-depth discussions on strengthening U.S.–India collaboration across the health technology sector, including biopharmaceuticals, genomics, precision medicine, and medical device manufacturing, with a focus on innovation, investment, and cross-border partnerships.